Join Vasuda Healthcare Analytics, and invest with Bhavneesh Sharma, MBBS, MD, MBA (Finance, NYU-Stern)

 
NYSE+interview.png

Applying Bayesian Statistics to select investments:

I invite you to try Vasuda Healthcare Analytics, a premium US Biotech/Pharma event-driven investment research service.

  • The service is targeted at investors who want to play biotech events like data releases, FDA decision dates, etc. profitably, with good reward/risk management using hedging by options, etc.

  • The service also provides a core portfolio of 30-40 biotech stocks which are swing traded around catalysts (focus on gene therapy and gene editing).

  • An additional bonus feature is daily early morning market outlook for the S&P 500 index, Biotech ETF XBI, and cryptos (bitcoin and ethereum) for swing or intraday trading.

Sna review VHA.png

I have 20-years of clinical and research experience in academic and private practice/community settings, including at Harvard and Cornell affiliated hospitals. I also have an MBA in Finance, Financial Markets specialization from New York University's Stern School of Business (ranked among the top 3 finance MBA programs in the U.S.). I run a biotech/pharma focused investment management firm, Vasuda Capital Management.

SA review VHA 2.png

I was ranked number one analyst on SumZero's Institutional Research Platform (May 2019) based on the performance of stock picks for the last 12 months, and was ranked #16 in the large-cap category among its worldwide pool of buy-side analysts for August.

SUMZERO LTM NO ONE RANKING.png

I am ranked among the top 15 financial bloggers on Tipranks based on the performance of stock picks. I have been invited for talks at prominent universities like MIT and NYU-Stern.

SA review VHA 3.png

The most important part of the service is the breaking insights and trade alerts on biotech/pharma companies that I post in the chat room. So please check the chat room at least once daily.

I attend investor and academic conferences regularly (for example, ASGCT annual conference, Cowen’s annual healthcare conference, Jefferies annual healthcare conference, etc.) and meet KOLs/experts/management, etc. My observations are shared with the subscribers only.

The second most important part of the service is the posts that I make suggestions on how to play biotech/pharma events using options.

The third most important part of the service is the daily swing trading alerts covering the S&P 500 Index, Biotech ETF XBI and cryptos like bitcoin and ethereum in the service chat room (which I do myself). 

Another very important part of the service is the ability to ask me questions, my opinion on individual biotech/pharma companies in the chat room and also gain insights from the trades of other members so that we can all benefit from over collective wisdom.

There are also spreadsheets on some recent short-term trades and long-term portfolio under ‘tools’. We trade around events in this service.

These subscriber-only features are not available on my contributions to the public Seeking Alpha site. 

SA review VHA 4.png

Several successful contrarian calls in the past include picking Juno after FDA trial hold till it got acquired at approx 4x gain, picking Tobira Therapeutics after trial failure for a 7x gain after acquisition, picking Vital Therapies after trial failure for 4x gain after reverse merger, picking Inotek Pharmaceuticals after trial failure for 4x gain after reverse merger, and picking Alnylam after FDA hold for a 2.5x gain.

I hope to see you in our investor community.

Bhavneesh Sharma, MD, MBA 
- Founder/Editor, Vasuda Healthcare Analytics
- Insights contributor, SumZero's Buy-side Institutional Platform

- Founder Biotech Analyst: FATrader.com
- Founder, Vasuda Capital Management 

Cumulative performance: Jan 2017 to September 2019

VCM cumulative accounts: outperforming benchmarks XBI and IBB (Biotech ETFs) since Jan. 2017. Details in the service spreadsheets. Updated performance is posted at the end of each month from real money client accounts (not a simulated portfolio).